BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23079497)

  • 1. Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives.
    El-Araby M; Omar A; Hassanein HH; El-Helby AG; Abdel-Rahman AA
    Molecules; 2012 Oct; 17(10):12262-75. PubMed ID: 23079497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
    Firke SD; Bari SB
    Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.
    Metwally NH; Mohamed MS
    Bioorg Chem; 2020 Jun; 99():103438. PubMed ID: 31796216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel imidazolone derivatives as potential COX-2 inhibitors.
    Hassanein HH; Khalifa MM; El-Samaloty ON; El-Rahim MA; Taha RA; Magda ; Ismail MF
    Arch Pharm Res; 2008 May; 31(5):562-8. PubMed ID: 18481009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
    Abdellatif KRA; Fadaly WAA
    Bioorg Chem; 2017 Jun; 72():123-129. PubMed ID: 28411407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
    Dube PN; Bule SS; Mokale SN; Kumbhare MR; Dighe PR; Ushir YV
    Chem Biol Drug Des; 2014 Oct; 84(4):409-19. PubMed ID: 24636540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity.
    Osman NA; Soltan MK; Rezq S; Flaherty J; Romero DG; Abdelkhalek AS
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300615. PubMed ID: 38315093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold.
    Ibrahim TS; Salem IM; Mostafa SM; El-Sabbagh OI; ElKhamisi MKM; Hegazy L; Elgendy B
    Bioorg Chem; 2020 Jul; 100():103878. PubMed ID: 32361486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
    Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anti-inflammatory activity and molecular docking studies of 2,5-diarylfuran amino acid derivatives.
    Stefani HA; Botteselle GV; Zukerman-Schpector J; Caracelli I; da Silva Corrêa D; Farsky SH; Machado ID; Santin JR; Hebeda CB
    Eur J Med Chem; 2012 Jan; 47(1):52-8. PubMed ID: 22071254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and bioactivities of Celecoxib analogues or derivatives.
    Zhou S; Yang S; Huang G
    Bioorg Med Chem; 2017 Sep; 25(17):4887-4893. PubMed ID: 28757100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocycles 48. Synthesis, Characterization and Biological Evaluation of Imidazo[2,1-
    Cristina A; Leonte D; Vlase L; Bencze LC; Imre S; Marc G; Apan B; Mogoșan C; Zaharia V
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30248903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.